MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Amphastar Pharmaceuticals Company Profile (NASDAQ:AMPH)

Consensus Ratings for Amphastar Pharmaceuticals (NASDAQ:AMPH) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.33 (17.45% upside)

Analysts' Ratings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016Needham & Company LLCLower Price TargetBuy$21.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Raymond JamesLower Price Target$23.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Jefferies GroupLower Price TargetBuy$18.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015BMO Capital MarketsBoost Price Target$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Piper JaffrayInitiated CoverageOverweight$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/10/2016        
5/9/2016Q1($0.03)$0.12$62.00 million$59.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q415($0.04)$0.19$64.48 million$76.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315($0.08)($0.01)$19.49 million$63.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215($0.11)($0.09)$19.49 million$53.85 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2015Q115($0.17)($0.01)$45.87 million$56.89 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/24/2015Q414($0.06)($0.03)$54.90 million$55.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.09)($0.07)$45.89 million$59.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014($0.11)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Amphastar Pharmaceuticals (NASDAQ:AMPH)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/15/2016Rong ZhouEVPSell1,551$15.85$24,583.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2016Richard K PrinsDirectorSell7,500$15.94$119,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Jason B ShandellPresidentSell9,904$16.43$162,722.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016William J PetersCFOSell2,297$16.00$36,752.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Jason B ShandellPresidentSell1,074$15.60$16,754.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Diane G GerstEVPSell1,427$13.97$19,935.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Richard K PrinsDirectorSell3,200$13.56$43,392.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/19/2016Diane G GerstEVPSell21,244$12.89$273,835.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Diane G GerstEVPSell15,637$12.83$200,622.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2016Richard K PrinsDirectorSell2,400$11.25$27,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Stephen B. ShohetDirectorSell30,770$14.19$436,626.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Howard LeeDirectorSell38,462$14.34$551,545.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Rong ZhouEVPSell772$14.29$11,031.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Jack Y ZhangCEOSell63,300$14.25$902,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Jack Y ZhangCEOSell68,117$14.71$1,002,001.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Jack Y ZhangCEOSell38,583$15.45$596,107.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Richard K PrinsDirectorSell9,100$14.66$133,406.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Richard K. PrinsDirectorSell5,400$14.70$79,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Michael A ZasloffDirectorSell7,692$17.41$133,917.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2015Rong ZhouEVPSell1,000$16.48$16,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Jack Y ZhangCEOSell45,382$16.29$739,272.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Jack Y ZhangCEOSell160,495$16.23$2,604,833.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Jack Y ZhangCEOSell193,758$16.43$3,183,443.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Richard K PrinsDirectorSell29,452$14.77$435,006.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2015Richard K PrinsDirectorSell3,000$14.94$44,820.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Marilyn J PurchaseVPSell28,000$15.79$442,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Diane G GerstSVPSell10,000$15.79$157,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Howard LeeDirectorBuy6,000$10.84$65,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Michael A ZasloffDirectorBuy3,500$10.00$35,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Richard K PrinsDirectorBuy4,000$10.02$40,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Floyd F PetersenDirectorBuy3,200$10.35$33,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Amphastar Pharmaceuticals (NASDAQ:AMPH)
DateHeadline
06/25/16 02:29 PMAnalyst's Ratings Review: Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) - iStreetWire
06/24/16 02:27 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Updated Price Targets - FTSE News
06/23/16 09:52 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) headlining after earnings - iStreetWire
06/21/16 07:14 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Current Analyst Ratings - Fiscal Standard
06/17/16 10:23 AMTrade-Ideas: Amphastar Pharmaceuticals (AMPH) Is Today's Weak On High Relative Volume Stock - TheStreet.com
06/14/16 07:15 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Trading Down – Insiders Are Selling
06/11/16 10:38 AMDurbin supports questioning of drugmakers' intent
06/10/16 03:14 PMAMPHASTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/09/16 11:21 AMAmphastar Pharmaceuticals Inc. (AMPH) is Trading Higher on Unusual Volume for June 07 - Equities.com
06/08/16 10:55 AMAMPHASTAR PHARMACEUTICALS INC. (NASDAQ:AMPH) Financial Condition Compared to S&P 500 - CML News
06/07/16 11:41 AMAdd These 5 Low Leverage Stocks to Your Portfolio -
06/07/16 10:32 AMSenators ask drugmakers about price increases for overdose antidote
06/06/16 07:46 PMSenators Probe Five Drugmakers Over Price of Overdose Antidote
06/04/16 02:30 PMWere Analysts Bullish Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Week? - HNN
06/04/16 10:56 AMJustices Told Hatch-Waxman Patent Safe Harbor Too Narrow
06/03/16 05:25 AMAmphastar Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - RANCHO CUCAMONGA, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies 2016 Healthcare ...
06/01/16 10:53 AMStock Review and Earnings Check on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - HNN - Stock Review and Earnings Check on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Amphastar Pharmaceuticals, Inc.and more »
06/01/16 10:53 AMAmphastar Pharmaceuticals Inc (DE) (AMPH) is Trading Higher on Unusual Volume for May 30 - Equities.com - Amphastar Pharmaceuticals Inc (DE) (AMPH) is Trading Higher on Unusual Volume for May 30Equities.comAmphastar Pharmaceuticals Inc (DE) (AMPH) experienced unusually high volume on May. 30, as the stock gained 2.01% to a closing price of $15.75. The stock saw 385,989 shares trade hands over the course of the day on 2,701 trades. Given that the stock's ...and more »
06/01/16 10:53 AMAnalysts and Technical Insights on Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) - Street Report - Analysts and Technical Insights on Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)Street ReportAmphastar Pharmaceuticals Inc (NASDAQ:AMPH) (Trend Analysis) shares were traded with a significant increase in volume. The stock closed last trading session at $15.73, down by -0.13%, with a volume of 364,665 shares against an average amount for the ...Stock Trending Up: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)The PostBroker Watchlist: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Share Trading Newsall 5 news articles »
05/31/16 09:53 AMMoving Average Crossover Alert: Amphastar (AMPH) -
05/28/16 10:26 AMHow Many Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)'s Analysts Are Bullish? - HNN - How Many Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)'s Analysts Are Bullish?HNNOut of 4 analysts covering Amphastar Pharmaceuticals (NASDAQ:AMPH), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Amphastar Pharmaceuticals has been the topic of 5 analyst reports since August 10, 2015 according to ...
05/26/16 10:35 AMEarnings Review and Stock Rundown for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Wall Street Hints and News - Earnings Review and Stock Rundown for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Amphastar Pharmaceuticals, Inc.
05/26/16 10:35 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Closes At $15.48 - Investor Newswire - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Closes At $15.48Investor NewswireYesterday, the stock of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) closed at $15.48 after opening at $15.50 and registering high of $15.60 and low of $15.09. The last price is $-2.88 off 1-year high of $18.30 and $4.92 away from low of $10.50 during ...and more »
05/23/16 08:36 AMCan The Uptrend Continue for Amphastar Pharmaceuticals (AMPH)? -
05/23/16 07:37 AMEarnings Estimates Moving Higher for Amphastar Pharmaceuticals (AMPH): Time to Buy? -
05/19/16 05:56 PMETF’s with exposure to Amphastar Pharmaceuticals, Inc. : May 19, 2016 -
05/18/16 12:04 PMAMPHASTAR PHARMACEUTICALS, INC. Financials -
05/17/16 12:52 PMAmphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 01:15 PMEdited Transcript of AMPH earnings conference call or presentation 9-May-16 9:00pm GMT -
05/09/16 04:42 PMAmphastar beats 1Q profit forecasts -
05/09/16 03:18 PMAmphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016 - [at noodls] - RANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ('Amphastar' or the 'Company') today reported results for the first quarter ended March 31, 2016. ...
05/09/16 06:07 AMQ1 2016 Amphastar Pharmaceuticals Inc Earnings Release - After Market Close -
05/06/16 05:14 AMAmphastar Pharmaceuticals to Present at the 2016 Bank of America Merrill Lynch 19th Annual Health Care Conference - [at noodls] - RANCHO CUCAMONGA, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Bank of America Merrill ...
03/15/16 01:37 PMWhat Is The ABR Of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)? - Investor Newswire - What Is The ABR Of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)?Investor NewswireZacks Research has reported Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to have ABR of 1.2. Investors always look out to invest in the companies that are considered as best performing in the industry. A group of investors acknowledges the value of ...and more »
03/15/16 01:11 PMAMPHASTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report -
03/15/16 10:10 AMEdited Transcript of AMPH earnings conference call or presentation 14-Mar-16 9:00pm GMT -
03/14/16 03:44 PMAmphastar posts 4Q profit -
03/14/16 03:15 PMAMPHASTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen -
03/14/16 03:06 PM4:06 pm Amphastar Pharmaceuticals beats by $0.23, beats on revs -
03/14/16 03:05 PMAmphastar Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2015 - [GlobeNewswire] - RANCHO CUCAMONGA, Calif., March 14, 2016-- Amphastar Pharmaceuticals, Inc. today reported results for the fourth quarter and fiscal year ended December 31, 2015.. Net revenues of $76.9 million for the ...
03/14/16 06:07 AMQ4 2015 Amphastar Pharmaceuticals Inc Earnings Release - After Market Close -
03/11/16 02:27 PMAmphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 14, 2016 - [GlobeNewswire] - RANCHO CUCAMONGA, Calif., March 11, 2016-- Amphastar Pharmaceuticals, Inc. announced that the Company will release results for its fourth quarter of 2015 ended December 31, 2015, after the market closes ...
02/26/16 09:11 AMWells Fargo Initiates Coverage on Amphastar Pharmaceuticals Inc to Outperform - SCSUCollegian - Wells Fargo Initiates Coverage on Amphastar Pharmaceuticals Inc to OutperformSCSUCollegianWells Fargo Initiates Coverage on Amphastar Pharmaceuticals Inc(NASDAQ:AMPH). The shares have been rated Outperform. The rating by Wells Fargo was issued on Feb 19, 2016. In a different note, On Jan 19, 2016, Jefferies said it Maintains its rating on ...and more »
02/19/16 01:59 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Analyst Updates - Risers & Fallers - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). According to the latest broker reports outstanding on Friday 19th of February, 2 analysts have a rating of “strong buy ...Amphastar Pharmaceuticals Inc (AMPH) is Initiated by Wells Fargo to OutperformLos Angeles MirrorAmphastar Pharmaceuticals Incorporated (NASDAQ:AMPH) Sellers Covered 1.12% of Their ShortsClinton Financialall 4 news articles »
02/19/16 07:24 AMCoverage initiated on Amphastar Pharmaceuticals by Wells Fargo -
02/18/16 01:41 PMOhio’s Heroin emergency - To help defray the cost and make Naloxone more accessible, my office negotiated with the drug’s manufacturer – Amphastar Pharmaceuticals, Inc. – who agreed to provide rebates for Naloxone syringes bought by non-federal Ohio agencies. Last year we ...
02/17/16 01:21 PMMike DeWine: Heroin death toll is mounting - To help defray the cost and make Naloxone more accessible, my office negotiated with the drug’s manufacturer – Amphastar Pharmaceuticals Inc. – who agreed to provide rebates for Naloxone syringes bought by non-federal Ohio agencies. Last year we ...
02/16/16 01:14 PMWe must end heroin epidemic - To help defray the cost and make Naloxone more accessible, my office negotiated with the drug’s manufacturer – Amphastar Pharmaceuticals, Inc. – who agreed to provide rebates for Naloxone syringes bought by non-federal Ohio agencies. Last year we ...
02/15/16 12:30 PMKilmartin announces increase for Rhode Island Naloxone rebate program - Attorney General Peter F. Kilmartin announced an amended agreement with Naloxone manufacturer Amphastar Pharmaceuticals Inc. that would increase the company-offered rebate for each Naloxone syringe dosage kit purchased by nonfederal government agencies in ...
02/14/16 11:56 AMOhio's heroin emergency - To help defray the cost and make Naloxone more accessible, my office negotiated with the drug’s manufacturer — Amphastar Pharmaceuticals, Inc. — who agreed to provide rebates for Naloxone syringes bought by non-federal Ohio agencies. Last year ...
About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals logoAmphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable and inhalation products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company manufactures and sells approximately 20 products. Additionally, the Company is developing a portfolio of approximately 10 generic abbreviated new drug applications (ANDA), over three generic biosimilar and over six injectable and inhalation product candidates.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AMPH
  • CUSIP:
Key Metrics:
  • Previous Close: $16.15
  • 50 Day Moving Average: $14.93
  • 200 Day Moving Average: $13.05
  • P/E Ratio: 7805.00
  • P/E Growth: 5.68
  • Market Cap: $700.03M
  • Current Quarter EPS Consensus Estimate: $0.11 EPS
Additional Links:
Amphastar Pharmaceuticals (NASDAQ:AMPH) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha